Press release from Companies
Publicerat: 2022-01-20 18:56:06
The shareholders of CS MEDICA A/S ("CS MEDICA" or the "Company") are hereby notified of an Extraordinary General Meeting that will be held on Tuesday February 3, 2022 at 17:00 at TEAMS. Shareholders will be entitled to vote by submitting postal vote forms prior to the meeting. Information about the resolutions passed at the meeting will be made public February 3, 2022 after the extraordinary general meeting has been held.
Registration
The registration date is 27 January 2022. Only those who are shareholders on this date have the right to participate and vote at the extraordinary general meeting.
In order to obtain access to the general meeting and thus to be able to participate in and vote at the general meeting, a shareholder must, no later than 2 days before the general meeting, request an admission card, cf. section 5.9 of the articles of association. Such request must be made to Elisabeth Bernhardt Jensen, e-mail ebj@cs-medica.com. The request must be received no later than 1. February 2022, at 11.59 PM (CET). A shareholder has also the possibility of requesting an admission card for a proxy holder who attends the general meeting by meeting on behalf of the shareholder. The request must be made according to the above guidelines. The shareholder must fill in and sign the proxy and postal voting form, enclosed as schedule 1 and which also can be found on the Company's website www.cs-medica.com. The proxy must bring the admission card and the original form at the general meeting.
Participation
To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register. Such registration must be duly effected in the share register on 27 January 2022, and the shareholders must therefore advise their nominees well in advance of such date.
The shareholders have the right to ask questions in relation to the issues on the agenda to be discussed at the general meeting. The questions can be made in writing before the general meeting or at the general meeting. The answer will - with the limitations that follow from the legislation - if possible be made at the general meeting or be made available to the shareholders no later than two weeks after the general meeting.
All material mentioned in this notice can be obtained from Elisabeth Bernhardt Jensen, e-mail ebj@cs-medica.com. The material will only be forwarded by e-mail, and thus the e-mail address must be specified.
Proposed agenda
The total numbers of votes as of the date of this notice is 10,902,000.
CS MEDICA A/S
On behalf of the board of directors
Jørgen Flemming Ladefoged, chairman
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on 20-01-2022 18:56 CET.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: "CSMED"). For more information about CS MEDICA cs-medica.com.
